Skip to main navigation Skip to search Skip to main content

Novel fibrillin 1 mutation in a case of neonatal marfan syndrome: The increasing importance of early recognition

  • Jamie Sutherell
  • , Yuri Zarate
  • , Bradley T. Tinkle
  • , Larry W. Markham
  • , Linda H. Cripe
  • , James C. Hyland
  • , David Witte
  • , Robert J. Hopkin
  • , Robert B. Hinton

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Neonatal Marfan syndrome (MFS) is a severe form of classic MFS caused by mutations in a specific region of the fibrillin 1 gene (FBN1). We report a case of an infant with neonatal MFS who presented with flexion contractures in utero and severe skeletal and cardiovascular manifestations at birth. A novel de novo missense mutation in exon 26 of FBN1 was demonstrated. Because of potential new therapies, it is increasingly important to recognize neonatal MFS in utero as well as shortly after birth to initiate the appropriate diagnostic work-up and management.

Original languageEnglish
Pages (from-to)342-346
Number of pages5
JournalCongenital Heart Disease
Volume2
Issue number5
DOIs
StatePublished - Sep 2007

Funding

FundersFunder number
National Heart, Lung, and Blood Institute (NHLBI)K23HL085122

    Keywords

    • Genetic Screening
    • Losartan
    • Marfan Syndrome
    • Prenatal Diagnosis

    ASJC Scopus subject areas

    • Pediatrics, Perinatology, and Child Health
    • Surgery
    • Radiology Nuclear Medicine and imaging
    • Cardiology and Cardiovascular Medicine

    Fingerprint

    Dive into the research topics of 'Novel fibrillin 1 mutation in a case of neonatal marfan syndrome: The increasing importance of early recognition'. Together they form a unique fingerprint.

    Cite this